CITIUS PHARMACEUTICALS INC (CTXR)
US17322U2078 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A 285.97% | N/A 53.20% | N/A 33.72% | N/A 15.82% | N/A 16.94% | N/A 11.86% | ||||||||||||
| EBITDA YoY % growth | N/A | N/A | N/A | -7.45M | -9.99M -34.09% | -13.79M -38.04% | -15.6M -13.13% | -17.71M -13.53% | -23.54M -32.92% | -33.32M -41.55% | -36.729M -10.23% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -30K | -650K -2,066.67% | -3.23M -396.92% | -7.45M -130.65% | -9.99M -34.09% | -13.79M -38.04% | -15.6M -13.13% | -17.71M -13.53% | -23.54M -32.92% | -33.32M -41.55% | -36.732M -10.24% | N/A -11.22% | N/A 79.64% | N/A 1,330.88% | N/A 72.18% | N/A 43.62% | N/A 17.86% | N/A 19.45% | N/A 13.15% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | -0.78 51.29% | -0.46 41.03% | -0.27 41.30% | -0.22 18.52% | N/A 25.82% | N/A -43.75% | N/A 102.17% | N/A 8,000.00% | N/A 5,825.93% | N/A 7.29% | N/A 5.83% | N/A 13.76% | N/A 6.45% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.53 -1,812.50% | -0.13 -112.50% | -0.13 89.80% | 0.13 108.50% | 0.13 108.33% | 4.59 3,700.00% | 4.59 3,700.00% | 4.85 3,700.00% | 5.36 4,100.00% |
| Revenue Q2Q % growth | 7.202M | 11.416M | 13.289M | 15.009M | 55.75M 674.09% | 58.174M 409.58% | 61.618M 363.68% | 66.85M 345.40% | |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -9.713M 4.07% | -10.762M -15.21% | -8.958M 18.35% | -8.409M 20.93% | -6.758M 30.43% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -1.50 -2,400.00% | -1.28 | -0.23 | -17.65% |
| Q2 2024 Q2Q % growth | -1.25 -1,685.71% | -1.53 | 0.28 | 18.30% |
| Q1 2024 Q2Q % growth | -0.06 | 0.13 | -0.19 | -145.25% |
| Q4 2023 Q2Q % growth | -0.08 -60.00% | -0.02 | -0.06 | -292.16% |
| Q3 2023 Q2Q % growth | -0.06 | -0.06 | 0.00 | -6.95% |
| Q2 2023 Q2Q % growth | -0.07 -40.00% | -0.04 | -0.03 | -96.08% |
| Q4 2022 Q2Q % growth | -0.05 -150.00% | -0.04 | -0.01 | -22.55% |
| Q3 2022 Q2Q % growth | -0.06 | -0.05 | -0.01 | -17.65% |
| Q2 2022 Q2Q % growth | -0.05 -25.00% | -0.07 | 0.02 | 29.97% |
| Q1 2022 Q2Q % growth | -0.06 60.00% | -0.06 | 0.00 | 1.96% |
| Q4 2021 Q2Q % growth | -0.02 71.43% | -0.04 | 0.02 | 50.98% |
| Q3 2021 Q2Q % growth | -0.06 45.45% | -0.07 | 0.01 | 9.50% |
| Q2 2021 Q2Q % growth | -0.04 69.23% | -0.08 | 0.04 | 47.71% |
| Q1 2021 Q2Q % growth | -0.15 | 0.16 | -0.31 | -191.91% |
| Q4 2020 Q2Q % growth | -0.07 56.25% | -0.11 | 0.04 | 34.64% |
| Q3 2020 Q2Q % growth | -0.11 45.00% | -0.11 | 0.00 | -2.71% |
| Q2 2020 Q2Q % growth | -0.13 35.00% | -0.10 | -0.03 | -27.45% |
| Q1 2020 Q2Q % growth | -0.15 31.82% | -0.14 | -0.01 | -5.04% |
| Q4 2019 Q2Q % growth | -0.16 27.27% | -0.14 | -0.02 | -12.04% |
| Q3 2019 Q2Q % growth | -0.20 -5.26% | % | ||
| Q2 2019 Q2Q % growth | -0.20 -5.26% | -0.20 | 0.00 | 1.96% |
| Q1 2019 Q2Q % growth | -0.22 | -0.21 | -0.01 | -2.71% |
| Q4 2018 Q2Q % growth | -0.22 | -0.21 | -0.01 | -2.71% |
| Q3 2018 Q2Q % growth | -0.19 | -0.33 | 0.14 | 41.79% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2024 Q2Q % growth | 21.721M | -21.721M | -100.00% | |
| Q1 2021 Q2Q % growth | 19.154M | -19.154M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -3650% | -3233.33% | -15% | -6.98% |
| Revenue | N/A | N/A | N/A | N/A |